Skip to main content
Michael Brenner, MD, Rheumatology, Boston, MA, Brigham and Women's Hospital

MichaelBBrennerMD

Rheumatology Boston, MA

Theodore Bevier Bayles Professor of Medicine, Brigham and Women's Hospital

Dr. Brenner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Brenner's full profile

Already have an account?

  • Office

    Brigham And Women's Hospital Rheumatology Immunology &
    60 Fenwood Rd. Rm 6002U
    Boston, MA 02115
    Phone+1 617-525-1000
  • Is this information wrong?

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Rheumatology, 1979 - 1982
  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterResidency, Internal Medicine, 1975 - 1979
  • Vanderbilt University School of Medicine
    Vanderbilt University School of MedicineClass of 1975

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1979 - Present
  • MA State Medical License
    MA State Medical License 1985 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

  • Fellow (FACR) American College of Rheumatology

Publications & Presentations

PubMed

Journal Articles

  • Metabolic Reprogramming of Natural Killer Cells in Obesity Limits Antitumor Responses  
    Ali Tavakkoli, Michael B Brenner, Kevin Wei, Ashley Vernon, Nature
  • Plateletpheresis-Associated Lymphopenia in Frequent Platelet Donors  
    Michael B Brenner, John M Gansner, A Helena Jonsson, Dan L Longo, Jason M Schenkel, Deepak A Rao, Richard M Kaufman, Nancy Berliner, Duane R Wesemann, Blood
  • High-Throughput Identification of Noncoding Functional SNPs via Type IIS Enzyme Restriction  
    Soumya Raychaudhuri, Jing Cui, Michael B Brenner, Peter A Nigrovic, Nature
  • Join now to see all

Press Mentions

  • Newborn Bio Business Mestag Therapeutics Raises $11m Seed Cash
    Newborn Bio Business Mestag Therapeutics Raises $11m Seed CashApril 26th, 2021
  • Mestag Therapeutics Launches with Seed Financing of $11 Million to Develop Therapeutics Targeting Activated Fibroblast Populations Across Inflammatory Disease and Cancer
    Mestag Therapeutics Launches with Seed Financing of $11 Million to Develop Therapeutics Targeting Activated Fibroblast Populations Across Inflammatory Disease and CancerApril 20th, 2021
  • U.S. Department of Defense Awards $3.3 Million Grant to Alivio Therapeutics
    U.S. Department of Defense Awards $3.3 Million Grant to Alivio TherapeuticsSeptember 12th, 2018
  • Join now to see all

Professional Memberships

Hospital Affiliations